Holen Sie sich die Stockscreener-App
3.71
4.13%
-0.16
Handel nachbörslich:
3.75
0.04
+1.08%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt LFMD?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$3.87
Offen:
$3.84
24-Stunden-Volumen:
758.81K
Relative Volume:
0.78
Marktkapitalisierung:
$179.42M
Einnahmen:
$219.42M
Nettoeinkommen (Verlust:
$-15.09M
KGV:
-8.9204
EPS:
-0.4159
Netto-Cashflow:
$-3.05M
1W Leistung:
-10.60%
1M Leistung:
-17.56%
6M Leistung:
+3.63%
1J Leistung:
-65.23%
1-Tages-Spanne:
$3.675
$3.875
1-Wochen-Bereich:
$3.675
$4.39
52-Wochen-Spanne:
$2.56
$12.72
Lifemd Inc Stock (LFMD) Company Profile
Firmenname
Lifemd Inc
Sektor
Branche
Telefon
(866) 351-5907
Adresse
236 FIFTH AVENUE, NEW YORK
Compare LFMD vs VEEV, BTSG, HQY, TEM, TXG
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LFMD
Lifemd Inc
|
3.71 | 179.42M | 219.42M | -15.09M | -3.05M | -0.4159 |
VEEV
Veeva Systems Inc
|
186.24 | 30.25B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
72.91 | 14.31B | 13.65B | 169.86M | 412.12M | 1.0758 |
HQY
Healthequity Inc
|
94.64 | 7.91B | 1.34B | 230.70M | 440.96M | 2.6695 |
TEM
Tempus Ai Inc
|
42.69 | 7.69B | 1.36B | -302.91M | -219.93M | -1.7182 |
TXG
10 X Genomics Inc
|
46.27 | 5.87B | 638.78M | -22.66M | 122.18M | -0.1744 |
Lifemd Inc Stock (LFMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-16 | Hochstufung | Mizuho | Neutral → Outperform |
| 2025-06-18 | Bestätigt | BTIG Research | Buy |
| 2024-12-10 | Eingeleitet | Lake Street | Buy |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-08-23 | Fortgesetzt | B. Riley Securities | Buy |
| 2024-06-05 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2023-11-30 | Eingeleitet | Craig Hallum | Buy |
| 2023-07-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-07-03 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-03-10 | Eingeleitet | Colliers Securities | Buy |
| 2021-10-04 | Fortgesetzt | B. Riley Securities | Buy |
Alle ansehen
Lifemd Inc Aktie (LFMD) Neueste Nachrichten
LFMD|LifeMD Inc|Price:3.710|Chg%:-0.160 - TradingKey
Lifemd, Inc. (LFMD) Q4 2023 Earnings ReportResults, Call & Slides - TipRanks
Lifemd, Inc. (LFMD) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
LifeMD to Report Second Quarter 2026 Financial Results on August 5 - The Manila Times
LifeMD schedules Aug. 5 update after U.S. markets close - Stock Titan
Lifemd, Inc. (LFMD) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
LifeMD (LFMD) Drops 3.6% as Stock Tests Key Support at $3.55Jurik MA - dars.gov.et
Telemedicine company touted by Novo Nordisk stressed profits over patient safety, ex-workers say - STAT
FEDERATED HERMES, INC. Acquires Significant Stake in LifeMD Inc - GuruFocus
LFMD News | LIFEMD INC (NASDAQ:LFMD) - ChartMill
LifeMD Inc. (LFMD) Declines 1.9%, Testing Key Support Near $4.41Volume Climax - dars.gov.et
B. Riley Names Top Digital Health Stock to Buy By Investing.com - Investing.com Australia
B. Riley Names Top Digital Health Stock to Buy - Investing.com India
LifeMD Rings the Nasdaq Stock Market Closing Bell - Nasdaq
LifeMD Rings the Closing Bell - Nasdaq
Federated Hermes reports 2.75M-share stake in LifeMD (LFMD) - Stock Titan
LifeMD Inc. (LFMD) Q1 2026 Earnings: EPS Beats Estimates Amid Revenue Disclosure GapConsensus Miss Rate - dars.gov.et
LifeMD, Inc. (NASDAQ:LFMD): Can the Penny Stock Story Continue? - Kalkine Media
LFMDP Q1 2026 Earnings: Narrower-Than-Expected Loss Sends Preferred Stock Slightly LowerGuidance Accuracy Score - dars.gov.et
Undiscovered Opportunities Penny Stocks To Consider In July 2026 - Sahm
(LFMD) Volatility Zones as Tactical Triggers - Stock Traders Daily
LFMDP Holds Steady at $23.4 as Preferred Stock Balances Yield Appeal and Technical ResistancePassive Flow - dars.gov.et
LFMDP Q1 2026 Earnings: Narrower Loss Surprises as Preferred Stock DeclinesEarnings Call Transcript - dars.gov.et
LifeMD Inc. (LFMDP) Q1 2026 Earnings: Preferred Shares Dip Despite Narrower-Than-Expected LossRevenue Guidance Range - dars.gov.et
LFMD Q1 2026 Earnings: Narrower-Than-Expected Loss Lifts SharesDividend Earnings Report - dars.gov.et
LFMD Q1 2026 Earnings: EPS Surpasses Estimates Despite Lack of Revenue DisclosureEarnings Yield Spread - dars.gov.et
B.Riley reiterates LifeMD stock Buy rating on telehealth expansion By Investing.com - Investing.com South Africa
B. Riley Securities Initiates LifeMD(LFMD.US) With Buy Rating, Announces Target Price $10 - Moomoo
B.Riley reiterates LifeMD stock Buy rating on telehealth expansion - Investing.com
LifeMD Inc. (LFMD) Q1 2026 Earnings: EPS Beat Partially Offsets Revenue UncertaintyTangible Book Value - dars.gov.et
LFMD SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
LFMD INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
LifeMD Inc. (LFMD) Q1 2026 Earnings: Narrower-Than-Expected Loss Signals Improved Cost DisciplineConsensus Beat Rate - dars.gov.et
LFMDP Q1 2026 Earnings: Preferred Stock Benefiting from Improved Operational Performance as Loss Narrower Than ExpectedQuarterly Earnings Report - dars.gov.et
Enterprise value to revenue forward of LifeMD, Inc. – NASDAQ:LFMD - TradingView
Price to book forward of LifeMD, Inc. – NASDAQ:LFMD - TradingView
Price to sales forward of LifeMD, Inc. – NASDAQ:LFMD - TradingView
LIFEMD INC PFD SER A 8.875% To Go Ex-Dividend On July 2nd, 2026 With 0.55469 USD Dividend Per Share - 富途牛牛
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock - Sahm
Best GLP-1 Medical Weight Loss Clinics in 2026 | Good Life Health - marketscreener.com
LifeMD Announces Exclusive Collaboration to Launch Direct-to-Patient Self-Pay Program for XYOSTED® (testosterone enanthate) Injection - Sahm
LifeMD, Inc. And Antares Pharma, Inc. Launch Direct-To-Patient Self-Pay Program For XYOSTED (Testosterone Enanthate) Injection - marketscreener.com
LifeMD Partners with Antares on XYOSTED Telehealth Program - TipRanks
LifeMD partners with Antares Pharma on testosterone program By Investing.com - Investing.com Nigeria
Form 8K LifeMD Inc For: 22 June By Investing.com - Investing.com South Africa
LifeMD partners with Antares Pharma on testosterone program - Investing.com
LifeMD to Launch Exclusive XYOSTED Self-Pay Telehealth Program in July across 37 States - TradingView
LifeMD (Nasdaq: LFMD) inks exclusive telehealth collaboration for XYOSTED self-pay program - Stock Titan
LifeMD and Halozyme Announce Exclusive Telehealth Co-Marketing Agreement for XYOSTED Self-Pay Program Launching in July 2026 - Quiver Quantitative
LifeMD, Halozyme link up to sell testosterone therapy online - Stock Titan
Finanzdaten der Lifemd Inc-Aktie (LFMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
Lifemd Inc-Aktie (LFMD) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| FRIEDEMAN JESSICA | Chief Marketing Officer |
Dec 09 '25 |
Sale |
3.61 |
15,000 |
54,158 |
205,000 |
1.99%
2.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):